Member Info for mathsprof

I don't really understand what your problem is. ATs may well reduce volatility - so bad for traders. What's the problem with GRPH? The majority of trades appear to be Os. Iceberg trading is one of those things that come and go on particular stocks - and can badly affect the SP on Aim I agree - but PDG is not now a penny stock, or on Aim. I suggest you find a stock you are more comfortable with, since the ATers are not going to go away.

Not at all phrased by the phase. It simply means that cash must be raised - which will obviously happen, but you can't say this in a 10-q.

More detail from 10-q filing: "We have insufficient cash flow to fund our current business plan beyond the middle of the first quarter of 2015 which raises substantial doubt about our ability to continue as a going concern beyond that date. Our total current assets, cash and working capital were approximately $8.3, $7.6 and $6.2 million, respectively, at June 30, 2014. We estimate that, after including the $10 million received from Baxter in January 2014, we have enough cash on hand to fund our current business plan to the middle of the first quarter of 2015. We will need to raise additional working capital either through equity or debt or a combination of equity and debt during 2014 to continue our current business plan." NASDAQ here we come - offers over $1, please.

Don't worry about the ATs. Most larger companies are computer traded in exactly the same way - eg just check the likes of INCH or LLOY. It doesn't make any difference to the price of the stock. The fact that we are bobbing up and down in this narrow bracket simply shows the current agreement on the fair value for the stock. We may think it should be more, but I'm afraid the expected good results are largely factored in by the market. There is ongoing general economic/world uncertainty which weighs more heavily on the car sector than others, I imagine.

Scott seems happy: "These results are very encouraging and are in agreement with the data from the other 96 subjects that have already been administered ErepoXen® during trials in India. We are delighted that ErepoXen® is performing well in this pivotal Western clinical trial. This new efficacy data demonstrates that we have a drug that could well allow the Company to make a major impact on the $7Bn global anemia market," said Scott Maguire, Chief Executive Officer of Xenetic. "We look forward to receiving the data on the additional cohorts at higher dose ranges to hopefully confirm the therapeutic value of ErepoXen®. We plan to seek a commercial partner with the resources to bring this large market drug candidate through late-stage clinical development and potential market launch."

try this instead: http://www.otcmarkets.com/stock/XBIO/news

http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=69608438&topic=XBIO&symbology=null&cp=off&webmasterId=89753

Yes, thanks, EyeGuy. Much of my portfolio not doing so well this year, but overall in profit. Hope you are doing well too.

Just what I've been waiting for. Excellent especially with increased dividend.

Yes. (perhaps) Someone was desperate to sell today at any price. No liquidity so a massive slump in price. A few weeks back the opposite happened when someone wanted to buy a reasonable amount.

What makes you think there is much shorting of PDG? Blackrock have a disclosed position of 0.55%, but there is no-one else over 0.5% I do agree though that we are in the middle of a little re-rate before interims. 36p perfectly possible before they're out.

Thank you. This explains all. Moved to OTC Link only because last MM pulled out of telephone quoting system. Electronic quotes now only. It should make no difference to us - but then, who can sensibly trade anyway?

Strange - XBIO seems to have been added and delated at the same time. Maybe something to do with the change notified last week. I had noticed not getting any quote yesterday, but yesterday's trades now seem to be reported. I don't think its anything to do with mve to NASDAQ.

Don't think so. It seems to me to be a step in the other direction! see http://www.sec.gov/answers/pink.htm We were traded on both OTC link and FINRA BB before. It looks like its only OTC link now. But, as you say probably has no significance.

If I didn't already hold as many as I wanted, I would certainly buy at this level. But don't take my advice - I'm biassed.

It's because they advertise in Autotrader. As for the SP slide, I am a bit perplexed. There is still a 20% or so discount to the likes of Inchcape and Lookers.

Seems to be some real interest now at prices under $1 - with some half-decent volume. I wonder if there's an institution picking up a few - I bet they've been suggested a price of $1+ for a potential placing price. Why not pick up a few at under $1. (Not mine at this price, though)

4. All three

What happen?

3564% per annum not bad eh! Why bother to invest in shares, then?